Clonidine is a medication used to treat high blood pressure, Attention Deficit Hyperactivity Disorder (ADHD), and anxiety disorders. It is a central alpha-2 agonist that works by decreasing the activity of the sympathetic nervous system, which regulates blood pressure and heart rate. It has been used for decades to treat these conditions, but like all medications, there is a risk of overdose. In this article, we will discuss the dangers of clonidine overdose, how to recognize the signs and symptoms, and how to avoid it.
Clonidine is a prescription medication used to treat high blood pressure, Attention Deficit Hyperactivity Disorder (ADHD), and anxiety disorders. It is a central alpha-2 agonist that works by decreasing the activity of the sympathetic nervous system, which regulates blood pressure and heart rate. It is usually taken as a pill, but can also be taken as a patch or liquid.
Clonidine overdose can be dangerous and even fatal. Signs and symptoms of a clonidine overdose may include: confusion, dizziness, drowsiness, dry mouth, nausea, vomiting, constipation, weakness, low blood pressure, slow heart rate, and respiratory depression. In severe cases, an overdose can lead to coma and death.
It is important to be aware of the signs and symptoms of a clonidine overdose. If you or someone you know is taking clonidine and is exhibiting any of the following symptoms, seek medical attention immediately: confusion, dizziness, drowsiness, dry mouth, nausea, vomiting, constipation, weakness, low blood pressure, slow heart rate, and respiratory depression.
The best way to avoid a clonidine overdose is to take the medication as prescribed by your doctor. Do not take more than the recommended dose and do not take it more often than prescribed.
Clonidine is a medication used to treat high blood pressure, Attention Deficit Hyperactivity Disorder (ADHD), and anxiety disorders. While it is effective in treating these conditions, there is a risk of overdose. The dangers of clonidine overdose include confusion, dizziness, drowsiness, dry mouth, nausea, vomiting, constipation, weakness, low blood pressure, slow heart rate, and respiratory depression.
1.
Health of Myeloma Patient's Marriage Tied to Recovery After Transplant
2.
Through Consolidation Durvalumab, Limited-Stage SCLC Receives a New Standard of Care.
3.
Tissue-Free ctDNA Strongly Prognostic of Recurrence in TNBC
4.
EBCC: European Breast Cancer Conference
5.
Charting the Course: From Young Adult Leukemia Patient to Oncologist.
1.
Frontiers in Cancer Therapeutics: U.S. Oncology Trials and Drug Discovery Trends
2.
A New Perspective on Spherocytosis: Uncovering Innovative Treatments
3.
Pathophysiology of Tumor Cell Extracellular Matrix Remodeling
4.
Innovative Advances in Oncology for Specialists
5.
Case Study: Diagnostic and Therapeutic Challenges in Aplastic Anemia Mimicking Hypoplastic Myelodysplastic Syndrome
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
An Eagles View - Evidence-based Discussion on Iron Deficiency Anemia- Panel Discussion III
2.
Importance of Cancer Screening and Early Detection
3.
Iron Deficiency Anemia: Ferric Maltol As a New Treatment Option
4.
Expert Group meeting with the management of EGFR mutation positive NSCLC - Part IV
5.
First Line Combination Therapy- The Overall Survival Data in NSCLC Patients
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation